Blueprint Medicines Corpo... (BPMC)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
104.97
2.41 (2.35%)
At close: Jan 15, 2025, 9:44 AM
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 |
Revenue | 249.38M | 204.04M | 180.08M | 793.74M | 66.51M | 44.52M | 21.43M | 27.77M | 11.40M | n/a | n/a |
Cost of Revenue | 12.80M | 17.81M | 17.93M | 425.00K | n/a | 243.62M | 144.69M | 81.13M | 48.59M | 31.84M | 15.93M |
Gross Profit | 236.58M | 186.22M | 162.15M | 793.31M | 66.51M | -199.10M | -123.26M | -53.36M | -37.19M | -31.84M | -15.93M |
Operating Income | -486.28M | -549.25M | -648.46M | 302.15M | -366.58M | -247.03M | -149.48M | -73.61M | -53.02M | -39.83M | -20.77M |
Interest Income | n/a | 17.75M | 2.39M | 6.60M | 13.73M | 10.64M | 3.42M | n/a | n/a | n/a | n/a |
Pretax Income | -506.02M | -552.28M | -641.08M | 314.94M | -347.69M | -236.64M | -148.12M | -72.50M | -52.77M | -40.28M | -20.91M |
Net Income | -506.98M | -557.52M | -644.09M | 313.88M | -328.70M | -236.64M | -148.12M | -72.50M | -52.77M | -40.28M | -20.91M |
Selling & General & Admin | 295.14M | 237.37M | 195.29M | 157.74M | 96.39M | 47.93M | 27.99M | 19.22M | 14.46M | 7.89M | 5.07M |
Research & Development | 427.72M | 477.42M | 601.03M | 326.86M | 331.45M | 243.62M | 144.69M | 81.13M | 48.59M | 31.84M | 15.93M |
Other Expenses | n/a | 8.95M | 7.80M | -366.00K | -100.00K | 10.46M | 3.35M | 551.00K | -429.00K | -98.00K | 226.00K |
Operating Expenses | 722.86M | 723.74M | 804.13M | 484.60M | 427.84M | 291.55M | 172.67M | 100.35M | 63.04M | 39.73M | 21.00M |
Interest Expense | n/a | 16.77M | n/a | n/a | 13.73M | 73.00K | 221.00K | 469.00K | 696.00K | 453.00K | 138.00K |
Selling & Marketing Expenses | 16.90M | 18.10M | 13.50M | 9.40M | 3.30M | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 735.66M | 741.55M | 822.06M | 485.03M | 427.84M | 291.55M | 172.67M | 100.35M | 63.04M | 39.73M | 21.00M |
Income Tax | 968.00K | 5.24M | 3.00M | 1.06M | -18.99M | 10.46M | 1.99M | -562.00K | -681.00K | 355.00K | 364.00K |
Shares Outstanding (Basic) | 60.56M | 59.64M | 58.52M | 54.53M | 47.83M | 43.87M | 37.79M | 27.49M | 18.24M | 13.08M | 13.08M |
Shares Outstanding (Diluted) | 60.56M | 59.64M | 58.52M | 56.17M | 47.83M | 43.87M | 37.79M | 27.49M | 18.24M | 13.08M | 13.08M |
EPS (Basic) | -8.37 | -9.35 | -11.01 | 5.76 | -6.87 | -5.39 | -3.92 | -2.64 | -2.89 | -3.08 | -1.6 |
EPS (Diluted) | -8.37 | -9.35 | -11.01 | 5.59 | -6.87 | -5.39 | -3.92 | -2.64 | -2.89 | -3.08 | -1.6 |
EBITDA | -470.36M | -515.41M | -628.30M | 308.71M | -356.07M | -242.78M | -149.67M | -70.44M | -51.13M | -39.11M | -20.50M |
Depreciation & Amortization | 11.66M | 20.10M | 12.79M | 12.35M | 10.25M | 4.25M | 1.58M | 1.58M | 948.00K | 622.00K | 501.00K |